GLSHQ (Gelesis Holdings) FCF Margin %: 54.11% (As of Jun. 2023)


What is Gelesis Holdings FCF Margin %?

Gelesis Holdings GLSHQ -99.00% FCF Margin % is 54.11% as of Jun. 2023.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Gelesis Holdings's Free Cash Flow for the three months ended in Jun. 2023 was $0.60 Mil. Gelesis Holdings's Revenue for the three months ended in Jun. 2023 was $1.11 Mil. Therefore, Gelesis Holdings's FCF Margin % for the quarter that ended in Jun. 2023 was 54.11%.

As of today, Gelesis Holdings's current FCF Yield % is 0.00%.

The historical rank and industry rank for Gelesis Holdings's FCF Margin % or its related term are showing as below:

GLSHQ' s FCF Margin % Range Over the Past 10 Years
Min: -414.58   Med: 0   Max: 0
Current: -414.58

GLSHQ's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -84.65 vs GLSHQ: -414.58

Gelesis Holdings FCF Margin % Related Terms

Gelesis Holdings FCF Margin % Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings FCF Margin % Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
FCF Margin %
-672.40 -337.05

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -85.73 -377.13 -643.91 -508.84 54.11

GLSHQ vs RBSH, PPCB, RGMP: FCF Margin % Comparison

For the Biotechnology subindustry, Gelesis Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gelesis Holdings FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gelesis Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Gelesis Holdings's FCF Margin % falls into.


Gelesis Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Gelesis Holdings's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-86.848/25.767
=-337.05 %

Gelesis Holdings's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=0.599/1.107
=54.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 54.11% mean?
Gelesis Holdings (GLSHQ) has a FCF Margin % of 54.11% as of Jun. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' FCF Margin % too high?
Gelesis Holdings' current FCF Margin % is 54.11%.
How does Gelesis Holdings' FCF Margin % compare to RBSH and PPCB?
Gelesis Holdings' FCF Margin % of 54.11% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current FCF Margin % is 54.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current FCF Margin % of 54.11%. The current FCF Margin % is 54.11%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current FCF Margin % is 54.11% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.